These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3119210)

  • 21. Avoiding ifosfamide/mesna encephalopathy.
    Meanwell CA; Kelly KA; Blackledge G
    Lancet; 1986 Aug; 2(8503):406. PubMed ID: 2874408
    [No Abstract]   [Full Text] [Related]  

  • 22. Ifosfamide and Mesna in advanced malignancies.
    Li GC; Brock N; Li JQ; Guan ZZ; He YJ
    Chin Med J (Engl); 1988 Mar; 101(3):213-20. PubMed ID: 3136996
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effects of mesna (2-mercaptoethane sodium sulfonate) in children with malignant disease receiving oxazaphosphorine chemotherapy].
    Iwasaku-Fujimoto M; Fujiwara F; Todo S; Morioka Y; Imashuku S
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):403-6. PubMed ID: 2106836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II trial of ifosfamide/mesna in metastatic adult renal carcinoma.
    De Forges A; Droz JP; Ghosn M; Theodore C
    Cancer Treat Rep; 1987 Nov; 71(11):1103. PubMed ID: 3119203
    [No Abstract]   [Full Text] [Related]  

  • 25. Ifosfamide, mesna and vincristine in paediatric oncology.
    de Kraker J; Voûte PA
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():165-6. PubMed ID: 6414690
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical overview of mesna.
    Burkert H
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():175-81. PubMed ID: 6414692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [High-dose ifosfamide therapy: systemic use of a mucolytic agent for the reduction of urotoxicity].
    Marti C; Steiner R; Viollier AF
    Schweiz Med Wochenschr; 1979 Dec; 109(47):1885-7. PubMed ID: 119317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Encephalopathy with rapid infusion ifosfamide/mesna.
    Perren TJ; Turner RC; Smith IE
    Lancet; 1987 Feb; 1(8529):390-1. PubMed ID: 2880199
    [No Abstract]   [Full Text] [Related]  

  • 29. Ongoing clinical studies of ifosfamide for pediatric cancer in the United States.
    Pratt CB
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):84-90. PubMed ID: 8677456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous infusions of ifosfamide/mesna and perturbation of warfarin anticoagulant control.
    Hall G; Lind MJ; Huang M; Moore A; Gane A; Roberts JT; Cantwell BM
    Postgrad Med J; 1990 Oct; 66(780):860-1. PubMed ID: 2129174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of N-acetylcysteine and mesna as uroprotectors with ifosfamide combination chemotherapy in refractory germ cell tumors.
    Munshi NC; Loehrer PJ; Williams SD; Langefeld C; Sledge G; Nichols CR; Roth BJ; Neuman A; Walsh WB; Einhorn LH
    Invest New Drugs; 1992 Aug; 10(3):159-63. PubMed ID: 1428725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central nervous system toxicity following the treatment of pediatric patients with ifosfamide/mesna.
    Pratt CB; Green AA; Horowitz ME; Meyer WH; Etcubanas E; Douglass E; Hayes FA; Thompson E; Wilimas J; Igarashi M
    J Clin Oncol; 1986 Aug; 4(8):1253-61. PubMed ID: 3090210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical evaluation of Mitexan in the prevention of urinary tract complications during treatment with Holoxan].
    Czownicki Z; Utracka-Hutka B
    Nowotwory; 1981; 30(4):377-83. PubMed ID: 6792599
    [No Abstract]   [Full Text] [Related]  

  • 34. Ifosfamide. Patient care management.
    Lynch MP; Ruland T
    Cancer Nurs; 1993 Oct; 16(5):362-5. PubMed ID: 8261384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral administration of mesna with ifosfamide.
    Goren MP
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):91-6. PubMed ID: 8677457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II trial of ifosfamide and mesna in previously treated patients with non-Hodgkin's lymphoma: Cancer and Leukemia Group B Study 8552.
    Case DC; Anderson J; Ervin TJ; Gottlieb A
    Med Pediatr Oncol; 1988; 16(3):182-6. PubMed ID: 3132591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ifosfamide-induced hemorrhagic cystitis and its prevention by mesna].
    Matsumoto S; Kawaguchi N; Manabe J; Kuroda H; Shimoji T
    Gan To Kagaku Ryoho; 1995 Jun; 22(7):965-8. PubMed ID: 7794006
    [No Abstract]   [Full Text] [Related]  

  • 38. Ifosfamide/mesa and encephalopathy.
    Cantwell BM; Harris AL
    Lancet; 1985 Mar; 1(8431):752. PubMed ID: 2858016
    [No Abstract]   [Full Text] [Related]  

  • 39. Combination chemotherapy with adriamycin, ifosfamide and mesna in extensive-stage non-small cell bronchogenic carcinoma.
    Matthiessen W; Stempinski E; Göbel D; Thalmann U
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():121-3. PubMed ID: 6414688
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of metastatic renal cancer with ifosfamide and mesnum with and without irradiation.
    Fosså SD; Talle K
    Cancer Treat Rep; 1980; 64(10-11):1103-8. PubMed ID: 6780190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.